Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/77441
DC FieldValueLanguage
dc.contributor.authorNazari, Amiren_US
dc.contributor.authorGonzález Lopez-Valcarcel, Beatrizen_US
dc.contributor.authorNajafi, Safaen_US
dc.date.accessioned2021-02-01T13:53:54Z-
dc.date.available2021-02-01T13:53:54Z-
dc.date.issued2021en_US
dc.identifier.issn2212-1099en_US
dc.identifier.otherScopus-
dc.identifier.urihttp://hdl.handle.net/10553/77441-
dc.description.abstractObjective: Some hormonal and targeted treatment options are available in the first line of metastatic HR+ & HER2- breast cancer. This study aimed to quantify the preferences of Iranian breast cancer patients regarding the levels of attributes of hypothetical treatment options. Methods: The discrete choice experiment included 16 orthogonally designed scenarios. A novel method (named “the World Cup”) was used to offer the scenarios to the respondents. Each choice task had 2 hypothetical treatments. A conditional logit regression model was used to obtain preference estimates, based on an expected utility model without interactions between attributes. Results: A total of 78 patients with breast cancer participated in the survey. The effectiveness was the main concern of the patient, which was followed by monthly cost. Participant patients significantly preferred to avoid adverse events; preference dummy-coded estimates were reported. Conclusion: Followed by the effectiveness and cost, the risk of neutropenia, stomatitis, and arthralgia was least prioritized by the respondents. The estimation for the levels of the attribute “administration mode” is not significant (P =. 690). Patients with breast cancer were willing to pay significant amounts to gain the benefit of the treatments and showed a significant willingness to accept to avoid the adverse events of the treatments.en_US
dc.languageengen_US
dc.relation.ispartofValue in Health Regional Issuesen_US
dc.sourceValue in Health Regional Issues[ISSN 2212-1099],v. 25, p. 7-14, (Septiembre 2021)en_US
dc.subject531207 Sanidaden_US
dc.subject.otherBreast Canceren_US
dc.subject.otherConjoint Analysisen_US
dc.subject.otherDceen_US
dc.subject.otherHormonal Therapyen_US
dc.subject.otherTargeted Therapyen_US
dc.subject.otherWorld Cup Methoden_US
dc.titlePreferences of patients with HR+ & HER2- breast cancer regarding hormonal and targeted therapies in the first line of their metastatic stage: a discrete choice experimenten_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.vhri.2020.10.002en_US
dc.identifier.scopus85099634485-
dc.contributor.authorscopusid57221616966-
dc.contributor.authorscopusid57218181419-
dc.contributor.authorscopusid16646492600-
dc.identifier.eissn2212-1102-
dc.description.lastpage14en_US
dc.description.firstpage7en_US
dc.relation.volume25en_US
dc.investigacionCiencias Sociales y Jurídicasen_US
dc.type2Artículoen_US
dc.utils.revisionen_US
dc.date.coverdateSeptiembre 2021en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-ECOen_US
dc.description.sjr0,395
dc.description.sjrqQ2
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR Economía de la salud y políticas públicas-
crisitem.author.deptDepartamento de Métodos Cuantitativos en Economía y Gestión-
crisitem.author.orcid0000-0002-5571-3257-
crisitem.author.parentorgDepartamento de Métodos Cuantitativos en Economía y Gestión-
crisitem.author.fullNameGonzález Lopez-Valcarcel, Beatriz-
Appears in Collections:Artículos
Show simple item record

Page view(s)

66
checked on Nov 20, 2021

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.